EUVIMEDEUVIMED entdecken
Open Access

The use of PD-1 functional knockout rats to study idiosyncratic adverse reactions to nevirapine

Tiffany Cho, Anthony Hayes, Jeffrey T Henderson, Jack Uetrecht

Toxicological Sciences · 2024

DOI: 10.1093/toxsci/kfae058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, 2024. Verfasst von Tiffany Cho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Leslie Dan Faculty of Pharmacy, Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario M5S 3M2, Canada. Hauptthemen laut MEDLINE: Nevirapine, Rats, Inbred BN, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Glaxo-Wellcome, Pfizer Canada, Glaxo-Wellcome Sunnybrook Drug Safety Clinic Graduate Student.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiosyncratic drug reactions (IDRs) are associated with significant patient morbidity/mortality and lead to considerable drug candidate attrition in drug development. Their idiosyncratic nature makes the study of IDRs difficult. In particular, nevirapine is associated with a relatively high risk of serious skin rash and liver injury. We previously found that nevirapine causes a similar skin rash in female Brown Norway rats, but these animals do not develop significant liver injury. Programmed cell death protein-1 (PD-1) is an immune checkpoint involved in immune tolerance, and anti-PD-1 antibodies have been used to treat cancer. However, they increase the risk of liver injury caused by co-administered drugs. We found that PD-1−/− mice are more susceptible to drug-induced liver injury, but PD-1−/− mice are not a good model for all drugs. In particular, they do not develop a skin rash when treated with nevirapine, at least in part because they lack the sulfotransferase in their skin that forms the reactive metabolite responsible for the rash. Therefore, we developed a PD-1 mutant (PD-1m/m) rat, with an excision in the ligand-binding domain of PD-1, to test whether nevirapine would cause a more serious skin rash in these animals. The PD-1m/m rat was based on a Sprague Dawley background, which has a lower incidence of skin rash than Brown Norway rats. The treated PD-1m/m rats developed more severe liver injury than PD-1−/− mice, but in contrast to expectations, they did not develop a skin rash. Functional knockouts provide a unique tool to study the mechanisms of IDRs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NevirapineRats, Inbred BNProgrammed Cell Death 1 ReceptorAnimalsFemaleRatsChemical and Drug Induced Liver InjuryGene Knockout TechniquesMale

Stichwörter der Autor:innen

PD-1adverse drug reactionsanimal modelsidiosyncratic drug reactionsidiosyncratic drug-induced liver injuryimmune tolerancenevirapineskin rash

Substanzen

NevirapineProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Leslie Dan Faculty of Pharmacy, Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario M5S 3M2, Canada.
  • Department of Pathobiology, University of Guelph, Guelph, Ontario N1G 2W1, Canada.

Förderung

  • Glaxo-Wellcome
  • Pfizer Canada
  • Glaxo-Wellcome Sunnybrook Drug Safety Clinic Graduate Student
  • CIHR
  • Wellcome Trust
  • Ontario Graduate Scholarship
  • Government of Canada
  • Genome Canada and Ontario Genomics

Zitieren

APA

Cho, T., Hayes, A., Henderson, J. T., & Uetrecht, J. (2024). The use of PD-1 functional knockout rats to study idiosyncratic adverse reactions to nevirapine. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfae058

Vancouver

Cho T, Hayes A, Henderson JT, Uetrecht J. The use of PD-1 functional knockout rats to study idiosyncratic adverse reactions to nevirapine. Toxicological Sciences. 2024. doi:10.1093/toxsci/kfae058

BibTeX
@article{Cho2024,
  author = {Cho, Tiffany and Hayes, Anthony and Henderson, Jeffrey T and Uetrecht, Jack},
  title = {The use of PD-1 functional knockout rats to study idiosyncratic adverse reactions to nevirapine},
  journal = {Toxicological Sciences},
  year = {2024},
  doi = {10.1093/toxsci/kfae058}
}
Kostenlos starten →